FR2356649A1 - Nouveaux sulfoxydes utilisables comme agents antibacteriens - Google Patents

Nouveaux sulfoxydes utilisables comme agents antibacteriens

Info

Publication number
FR2356649A1
FR2356649A1 FR7717835A FR7717835A FR2356649A1 FR 2356649 A1 FR2356649 A1 FR 2356649A1 FR 7717835 A FR7717835 A FR 7717835A FR 7717835 A FR7717835 A FR 7717835A FR 2356649 A1 FR2356649 A1 FR 2356649A1
Authority
FR
France
Prior art keywords
sulfoxides
new
antibacterial agents
relates
antibacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7717835A
Other languages
English (en)
French (fr)
Other versions
FR2356649B1 (en, 2012
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of FR2356649A1 publication Critical patent/FR2356649A1/fr
Application granted granted Critical
Publication of FR2356649B1 publication Critical patent/FR2356649B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR7717835A 1976-06-30 1977-06-10 Nouveaux sulfoxydes utilisables comme agents antibacteriens Granted FR2356649A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB27201/76A GB1577725A (en) 1976-06-30 1976-06-30 Azetidinone derivatives

Publications (2)

Publication Number Publication Date
FR2356649A1 true FR2356649A1 (fr) 1978-01-27
FR2356649B1 FR2356649B1 (en, 2012) 1980-03-07

Family

ID=10255829

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7717835A Granted FR2356649A1 (fr) 1976-06-30 1977-06-10 Nouveaux sulfoxydes utilisables comme agents antibacteriens

Country Status (5)

Country Link
US (1) US4210662A (en, 2012)
JP (1) JPS535195A (en, 2012)
DE (1) DE2728097A1 (en, 2012)
FR (1) FR2356649A1 (en, 2012)
GB (1) GB1577725A (en, 2012)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0001265A1 (en) * 1977-09-15 1979-04-04 Merck & Co. Inc. O-, N- and carboxyl derivatives of thienamycin sulfoxide and sulfone, their preparation and pharmaceuticals containing said compounds
EP0007753A1 (en) * 1978-08-02 1980-02-06 Beecham Group Plc Beta-lactam antibacterial agents, a process for their preparation and pharmaceutical compositions containing them
EP0008497A1 (en) * 1978-07-26 1980-03-05 Beecham Group Plc Beta-lactam-containing compounds, their preparation and pharmaceutical compositions containing them

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2862419D1 (en) * 1977-11-12 1984-07-26 Beecham Group Plc Derivatives of 7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid, their preparation, pharmaceutical compositions containing them and intermediates
AU534530B2 (en) * 1979-02-02 1984-02-02 Takeda Chemical Industries Ltd. 5-aza-(3.2.0)-heptane derivatives
US4530791A (en) * 1979-04-16 1985-07-23 Kowa Co., Ltd. β-Lactam antibiotics
EP0067518B1 (en) * 1981-05-14 1985-08-21 Beecham Group Plc Modified beta-lactam compounds
US4647408A (en) * 1983-02-01 1987-03-03 Shionogi & Co., Ltd. Carbapenem-type antibiotics
RU2146172C1 (ru) * 1999-07-29 2000-03-10 Институт катализа им.Г.К.Борескова СО РАН Каталитическая композиция, способ ее приготовления и способ очистки терефталевой кислоты

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2344558A1 (fr) * 1976-03-16 1977-10-14 Merck & Co Inc Thienamycine sulfoxyde et sulfone utiles comme medicaments

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000129A (en) * 1970-02-18 1976-12-28 Koninklijke Nederlandsche Gist-En Spiritusfabriek N.V. 6-aminopenicillanic acid sulfoxide silyl esters
US3928569A (en) * 1972-08-09 1975-12-23 Microbial Chem Res Found Two substances inhibiting beta-lactamase and their production
CA1061779A (en) * 1974-08-29 1979-09-04 Toshiyasu Ishimaru Cephalosporin esters
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics
US4123547A (en) * 1977-08-04 1978-10-31 Merck & Co., Inc. Thienamycin sulfoxide and sulphone
US4150145A (en) * 1977-09-15 1979-04-17 Merck & Co., Inc. N-alkylated derivatives of thienamycin sulfoxide and sulfone

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2344558A1 (fr) * 1976-03-16 1977-10-14 Merck & Co Inc Thienamycine sulfoxyde et sulfone utiles comme medicaments

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0001265A1 (en) * 1977-09-15 1979-04-04 Merck & Co. Inc. O-, N- and carboxyl derivatives of thienamycin sulfoxide and sulfone, their preparation and pharmaceuticals containing said compounds
EP0008497A1 (en) * 1978-07-26 1980-03-05 Beecham Group Plc Beta-lactam-containing compounds, their preparation and pharmaceutical compositions containing them
EP0007753A1 (en) * 1978-08-02 1980-02-06 Beecham Group Plc Beta-lactam antibacterial agents, a process for their preparation and pharmaceutical compositions containing them
US4444783A (en) * 1978-08-02 1984-04-24 Beecham Group Limited β-Lactam antibacterial agents, a process for the preparation and use in pharmaceutical compositions

Also Published As

Publication number Publication date
DE2728097A1 (de) 1978-01-12
GB1577725A (en) 1980-10-29
US4210662A (en) 1980-07-01
JPS535195A (en) 1978-01-18
FR2356649B1 (en, 2012) 1980-03-07

Similar Documents

Publication Publication Date Title
FR2370051A1 (fr) Nouveaux benzamides substitues utilisables comme medicaments
FR2383171A1 (fr) Derives de thiopropanoylaminoacides utiles comme hypotenseurs
FR2355017A1 (fr) Acide monique utilisable comme agent antibacterien
FR2389605A1 (en, 2012)
FR2361868A1 (fr) Composes polycycliques
FR2381762A1 (fr) Dibenzodiazepines utilisables comme antischizophreniques
FR2361340A1 (fr) Nouvelles anilines substituees utilisables comme medicament
FR2356649A1 (fr) Nouveaux sulfoxydes utilisables comme agents antibacteriens
FR2434802A1 (fr) Oxime-carbamates et carbonates utiles pour la protection des cultures
FR2383605A1 (fr) Regulateurs de la croissance des vegetaux
FR2387955A1 (fr) Derives de l'aniline utilisables comme medicament
FR2446838A1 (fr) Derives peptidiques d'acides phosphoniques
FR2385728A1 (fr) Acides n-sulfoalkyl-amino-alcane-phosphoniques utilisables comme complexants
FR2384745A1 (fr) Derives de la somatostatine et leur preparation
FR2357517A1 (fr) Procede de production d'halogenophenols
FR2398731A1 (fr) Nouveaux derives du maleinimide et du succinimide utiles comme herbicides
FR2400008A1 (fr) Agents anti-hypertensifs
FR2359131A1 (fr) Agents cardiovasculaires a base de thiazoles
FR2399465A1 (fr) Nouveaux complexes chromiferes 1 : 2, leur preparation et leur application comme colorants
FR2387215A1 (fr) 4-alcoylthio-2-trifluoromethylalcanesulfonanilides et leurs derives
FR2377997A1 (fr) Aralcoylanilines utilisables comme medicament
FR2362148A1 (fr) Composes silices polyethyleniques
FR2426688A1 (fr) Nouvelles neplanocines antibiotiques
FR2430937A1 (fr) Triiodo-benzonitriles et agents de diagnostic qui en contiennent
FR2446835A1 (fr) Octahydro-2h-pyrrolo(3,4-g)quinoleines utiles comme intermediaires

Legal Events

Date Code Title Description
ST Notification of lapse